Prentiss Christopher B

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2021-03-23	2021-03-22	Adamas Pharmaceuticals Inc (ADMS)	S Sale	23,552 -45.9% 168.30 US$1,754,007	23,552 -45.9%	168.30	US$1,754,007
2021-02-01	2021-02-01	Adamas Pharmaceuticals Inc (ADMS)	S Sale	63,768 +33.6% 137.26 US$742,110	63,768 +33.6%	137.26	US$742,110
2021-01-22	2021-01-20	Adamas Pharmaceuticals Inc (ADMS)	S Sale	8,446 -28.3% 190.32 US$339,208	8,446 -28.3%	190.32	US$339,208
2020-11-02	2020-11-02	Adamas Pharmaceuticals Inc (ADMS)	S Sale	2,050 -2.5% 3.21 US$6,580	2,050 -2.5%	3.21	US$6,580
2020-01-23	2020-01-21	Adamas Pharmaceuticals Inc (ADMS)	S Sale	1,269 -1.8% 5.92 US$7,512	1,269 -1.8%	5.92	US$7,512
2019-07-23	2019-07-22	Adamas Pharmaceuticals Inc (ADMS)	S Sale	1,082 -2.2% 6.00 US$6,492	1,082 -2.2%	6.00	US$6,492
2019-03-21	2019-03-20	Adamas Pharmaceuticals Inc (ADMS)	S Sale	1,185 -3.9% 8.00 US$9,480	1,185 -3.9%	8.00	US$9,480